https://staging2.gcaresearch.org/news/kintara-announces-first-international-site-activation-in-gcar-phase-2-3-clinical-trial-for-glioblastoma/ 2023-07-24T02:28:24+00:00 https://staging2.gcaresearch.org/news/gbm-agile-opens-to-paxalisib-in-canada/ 2023-07-24T02:35:48+00:00 https://staging2.gcaresearch.org/news/gbm-agile-opens-to-paxalisib-in-europe/ 2023-07-24T03:38:52+00:00 https://staging2.gcaresearch.org/news/kintara-announces-first-european-site-activation-in-switzerland-in-gcar-phase-2-3-clinical-trial-for-glioblastoma/ 2023-07-24T03:38:56+00:00 https://staging2.gcaresearch.org/news/interleukin-6-receptor-antagonists-in-critically-ill-patients-with-covid-19/ 2023-07-24T03:55:46+00:00 https://staging2.gcaresearch.org/news/implementation-of-the-randomized-embedded-multifactorial-adaptive-platform-for-covid-19-remap-covid-trial-in-a-us-health-system-lessons-learned-and-recommendations/ 2023-07-24T03:57:30+00:00 https://staging2.gcaresearch.org/news/full-dose-blood-thinners-decreased-need-for-life-support-and-improved-outcome-in-hospitalized-covid-19-patients/ 2023-07-24T03:58:25+00:00 https://staging2.gcaresearch.org/news/therapeutic-anticoagulation-with-heparin-in-noncritically-ill-patients-with-covid-19/ 2023-07-24T04:02:26+00:00 https://staging2.gcaresearch.org/news/kintara-and-the-global-coalition-for-adaptive-research-execute-agreement-for-val-083s-participation-in-the-gbm-agile-registrational-study/ 2023-07-24T04:21:06+00:00 https://staging2.gcaresearch.org/news/kazia-executes-agreement-to-commence-gbm-agile-pivotal-study/ 2023-07-24T04:22:12+00:00 https://staging2.gcaresearch.org/news/corticosteroids-improve-survival-in-critically-ill-covid-19-patients/ 2023-07-24T04:25:57+00:00 https://staging2.gcaresearch.org/news/effect-of-hydrocortisone-on-mortality-and-organ-support-in-patients-with-severe-covid-19-the-remap-cap-covid-19-corticosteroid-domain-randomized-clinical-trial/ 2023-07-24T04:26:54+00:00 https://staging2.gcaresearch.org/news/steroids-can-be-lifesaving-for-covid-19-patients-scientists-report/ 2023-07-24T04:27:58+00:00 https://staging2.gcaresearch.org/news/remap-cap-to-partner-with-eisai-on-innovative-trial-to-combat-covid/ 2023-07-24T04:28:55+00:00 https://staging2.gcaresearch.org/news/delmar-pharmaceuticals-receives-500000-loan-from-the-national-brain-tumor-society-and-national-foundation-for-cancer-research-to-support-val-083s-participation-in-a-pivotal-study-for-gliobl/ 2023-07-24T04:30:33+00:00 https://staging2.gcaresearch.org/news/global-coalition-for-adaptive-research-gcar-selects-delmar-pharmaceuticals-val-083-to-participate-in-the-gbm-agile-pivotal-study-an-adaptive-clinical-trial-platform-in-glioblastoma-multifo/ 2023-07-24T04:31:42+00:00 https://staging2.gcaresearch.org/news/chasing-a-cure-for-gbm-investigators-test-multiple-regimens-in-novel-trial/ 2023-07-24T04:33:22+00:00 https://staging2.gcaresearch.org/news/international-trial-uses-ai-to-rapidly-identify-optimal-covid-19-treatments/ 2023-07-24T04:34:39+00:00 https://staging2.gcaresearch.org/news/kazia-initiates-preparatory-activities-to-bring-gdc-0084-into-gbm-agile-an-international-phase-ii-iii-study-in-glioblastoma/ 2023-07-24T04:35:43+00:00 https://staging2.gcaresearch.org/news/fdas-woodcock-defends-accelerated-approvals-and-talks-of-culture-shift-in-clinical-trials/ 2023-07-24T04:48:37+00:00 https://staging2.gcaresearch.org/news/national-brain-tumor-society-invests-in-gbm-agile-the-worlds-first-global-adaptive-trial-for-glioblastoma/ 2023-07-24T04:54:14+00:00 https://staging2.gcaresearch.org/news/4-ways-cancer-is-changing-how-we-test-medicines/ 2023-07-24T04:59:23+00:00 https://staging2.gcaresearch.org/news/could-a-new-business-model-make-clinical-drug-trials-more-accessible-to-patients/ 2023-07-24T05:03:21+00:00 https://staging2.gcaresearch.org/news/new-funding-partnership-bolsters-support-for-first-global-adaptive-clinical-trial-platform-for-brain-cancer-patients/ 2023-07-26T22:05:37+00:00 https://staging2.gcaresearch.org/news/henry-ford-cancer-institute-is-first-in-the-world-to-activate-two-new-treatments-in-gbm-agile-trial-for-glioblastoma/ 2023-07-26T22:06:04+00:00 https://staging2.gcaresearch.org/news/global-coalition-for-adaptive-research-amgen-and-eisai-announce-first-patient-enrolled-in-international-covid-19-trial/ 2023-10-19T04:15:41+00:00 https://staging2.gcaresearch.org/news/bayers-stivarga-regorafenib-becomes-first-compound-used-in-clinical-trial-platform-to-investigate-new-therapies-for-brain-cancer/ 2023-10-19T04:17:08+00:00 https://staging2.gcaresearch.org/news/kintara-therapeutics-announces-preliminary-topline-results-from-gbm-agile-study/ 2023-11-02T00:54:20+00:00 https://staging2.gcaresearch.org/news/global-coalition-for-adaptive-research-announces-that-regorafenib-has-completed-follow-up-in-the-gbm-agile-trial-for-patients-with-glioblastoma/ 2025-06-12T08:54:48+00:00 https://staging2.gcaresearch.org/news/global-coalition-for-adaptive-research-gcar-appoints-jeffrey-tarrant-to-board-of-directors/ 2025-06-12T08:55:35+00:00 https://staging2.gcaresearch.org/news/global-coalition-for-adaptive-research-joins-the-south-pole-trek-4-cancer-to-raise-money-for-cancer-research/ 2025-06-12T08:56:55+00:00 https://staging2.gcaresearch.org/news/investigational-drug-tinostamustine-to-be-included-in-gbm-agile-clinical-trial-for-glioblastoma/ 2025-09-17T23:08:50+00:00 https://staging2.gcaresearch.org/news/global-coalition-for-adaptive-research-biohaven-and-vigeo-announce-commencement-of-biohavens-troriluzole-and-vigeos-vt1021-in-gbm-agile-trial/ 2025-10-28T21:45:45+00:00 https://staging2.gcaresearch.org/news/global-coalition-for-adaptive-researchs-innovative-clinical-trial-platform-opens-to-evaluate-new-therapies-for-brain-cancer/ 2025-10-28T21:51:46+00:00 https://staging2.gcaresearch.org/news/ovarian-cancerx-new-innovative-clinical-research-effort-seeks-to-accelerate-the-development-of-new-treatments-for-deadliest-gynecological-cancer/ 2025-10-28T21:53:55+00:00 https://staging2.gcaresearch.org/news/global-coalition-for-adaptive-research-and-polaris-group-announce-commencement-of-adi-peg-20-in-gbm-agile-trial/ 2025-10-28T22:41:37+00:00 https://staging2.gcaresearch.org/news/global-platform-study-presents-results-to-guide-care-of-severely-ill-patients-with-covid-19-using-routinely-available-drugs-simvastatin-and-vitamin-c/ 2025-10-28T22:42:03+00:00 https://staging2.gcaresearch.org/news/global-coalition-for-adaptive-research-announces-key-updates-on-gbm-agile-phase-2-3-adaptive-platform-trial-for-patients-with-glioblastoma/ 2025-10-28T22:43:00+00:00 https://staging2.gcaresearch.org/news/global-coalition-for-adaptive-research-and-gbm-agile-partners-to-ring-the-nasdaq-stock-market-closing-bell-in-honor-of-national-brain-tumor-awareness-month/ 2025-10-28T22:43:45+00:00 https://staging2.gcaresearch.org/news/global-coalition-for-adaptive-research-in-collaboration-with-cure-brain-cancer-foundation-announce-the-opening-of-glioblastoma-clinical-trial-in-australia/ 2025-10-28T22:44:27+00:00 https://staging2.gcaresearch.org/news/global-coalition-for-adaptive-research-kazia-and-kintara-announce-commencement-of-kazias-paxalisib-and-kintaras-val-083-in-gbm-agile-trial/ 2025-10-28T22:46:33+00:00 https://staging2.gcaresearch.org/news/the-pancreatic-cancer-action-network-and-the-global-coalition-for-adaptive-research-forge-a-powerful-alliance-to-accelerate-treatment-options-for-pancreatic-cancer-patients/ 2025-10-28T22:48:48+00:00 https://staging2.gcaresearch.org/news/global-coalition-for-adaptive-research-announces-initiation-of-azd1390-in-gbm-agile-trial/ 2025-10-28T22:55:27+00:00 https://staging2.gcaresearch.org/news/global-coalition-for-adaptive-research-launches-to-speed-the-discovery-development-of-cures-for-patients-with-rare-deadly-diseases/ 2025-10-28T22:56:52+00:00 https://staging2.gcaresearch.org/news/childrens-tumor-foundation-and-global-coalition-for-adaptive-research-announce-strategic-alliance-to-implement-nf-platform-clinical-trial/ 2025-10-28T22:57:55+00:00 https://staging2.gcaresearch.org/news/bayers-regorafenib-is-the-first-drug-to-enter-gbm-agile/ 2025-10-28T22:58:58+00:00 https://staging2.gcaresearch.org/news/global-coalition-for-adaptive-research-announces-the-discontinued-evaluation-of-apremilast-in-remap-covid/ 2025-10-28T22:59:57+00:00 https://staging2.gcaresearch.org/news/global-coalition-for-adaptive-research-gcar-names-gary-gordon-interim-chief-executive-officer/ 2025-10-28T23:00:48+00:00 https://staging2.gcaresearch.org/news/u-s-department-of-defense-taps-global-coalition-for-adaptive-research-to-be-the-regulatory-lead-for-ptsd-trial/ 2026-01-16T18:59:17+00:00 https://staging2.gcaresearch.org/news/gcar-welcomes-financial-visionary-andrew-lo-to-board-of-directors/ 2026-01-30T17:25:23+00:00 https://staging2.gcaresearch.org/news/global-coalition-for-adaptive-research-announces-evaluation-of-azd1390-in-gbm-agile-trial/ 2026-01-30T20:15:31+00:00 https://staging2.gcaresearch.org/news/global-coalition-for-adaptive-research-announces-the-discontinued-evaluation-of-eritoran-in-remap-covid/ 2026-01-30T20:16:34+00:00 https://staging2.gcaresearch.org/news/global-coalition-for-adaptive-research-gcar-names-meredith-buxton-chief-operating-officer/ 2026-01-30T20:17:35+00:00 https://staging2.gcaresearch.org/news/gcar-and-purdue-pharma-l-p-announce-initiation-of-tinostamustine-in-gbm-agile-trial/ 2026-04-08T14:04:27+00:00 https://staging2.gcaresearch.org/news/knoa-pharma-and-gcar-announce-first-newly-diagnosed-glioblastoma-patient-randomized-in-phase-2-3-gbm-agile-evaluation-of-tinostamustine-and-first-recurrent-patient-dosed/ 2026-06-24T15:39:26+00:00 https://staging2.gcaresearch.org/news/colorectal-cancer-alliance-and-gcar-announce-collaboration-to-advance-a-groundbreaking-adaptive-clinical-trial-platform-for-colorectal-cancer-kleos/ 2026-06-24T15:39:45+00:00